Full-Time

Senior Regulatory Affairs Director

Confirmed live in the last 24 hours

Deadline 8/2/25
AstraZeneca

AstraZeneca

10,001+ employees

Develops and commercializes prescription medicines

No salary listed

Senior, Expert

Sant Cugat del Vallès, Barcelona, Spain

In Person

Category
Legal
Risk & Compliance
Legal & Compliance
Requirements
  • An advanced degree in a science related field and/or other appropriate knowledge/experience.
  • Previous demonstrated experience of regulatory drug development including product approval/launch. Successful leadership to at least one major regulatory approval at a global level including leading response team and labeling negotiations is desired.
  • Previous experience in leading major health authority interactions.
  • Solid knowledge of regulatory affairs within several therapeutic areas in early and late development.
  • Broad background of experience working in pharmaceutical business and prior experience in several areas within regulatory affairs. Experience in relevant therapy area (small molecules & biologics) is preferred.
  • Proven leadership experience.
  • Ability to think strategically and critically and evaluate risks to regulatory activities.
  • Deep understanding of global regulatory science and will integrate with project strategy. You have a long standing experience of overall drug/biologic development processes and strategies for high profile, complex or novel development programs.
Responsibilities
  • Lead a Global Regulatory Strategy Team (GRST) of GRLs within the franchise, contributing members from the regions, emerging markets, RA CMC, Labelling and members of the submission and execution team.
  • Ensure that the strategy is crafted to deliver approval with competitive labelling in keeping with the properties of the product(s) and the needs identified by the business, markets and patients.
  • Lead the assessment of emerging data against aspirations and update Leadership on project risks/mitigation activities.
  • Represent Regulatory Affairs on Global Product Teams (GPTs) providing strategic advice and accountable for all regulatory activities.
  • Own the delivery of all milestones on your team including assessment of the probability of regulatory success based on a detailed assessment of risks and mitigations.
  • Demonstrate strategic leadership skills thereby contributing to effective product development.
  • Promote novel regulatory initiatives internally and engage externally on the corresponding topics. Lead the development of novel tools and technology.
  • Partner and influence developing views/guidance on a global scale.
Desired Qualifications
  • Previous experience with FDA advisory committee and EMA oral explanation hearings would be a plus
  • Previous experience working on due diligence activities and in a business alliance environment.
  • Ability to work strategically within a complex, business critical and high-profile development program.

AstraZeneca develops and sells prescription medicines, focusing on three main areas: Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. The company conducts extensive research and development, with new drugs undergoing rigorous clinical trials and regulatory approvals before reaching the market. AstraZeneca stands out from competitors through its collaborative approach, including its Open Innovation program and the A.Catalyst Network, which connects health innovation hubs worldwide. The company's goal is to advance healthcare by creating effective treatments for serious diseases.

Company Size

10,001+

Company Stage

IPO

Headquarters

Cambridge, United Kingdom

Founded

1913

Simplify Jobs

Simplify's Take

What believers are saying

  • AstraZeneca's AI partnership with Sheffield enhances protein folding and drug discovery.
  • The expansion in Bangalore creates 400 jobs, boosting AstraZeneca's global operations.
  • Strategic stake in Niox Group offers collaboration opportunities in the pharmaceutical sector.

What critics are saying

  • Expansion in Bangalore may face challenges from local regulatory changes.
  • Stake in Niox Group exposes AstraZeneca to financial risks if Niox underperforms.
  • CSPC collaboration may be affected by geopolitical tensions or trade restrictions.

What makes AstraZeneca unique

  • AstraZeneca focuses on three main therapy areas: Oncology, Cardiovascular, and Respiratory.
  • The company invests heavily in R&D to create innovative prescription medicines.
  • AstraZeneca's A.Catalyst Network fosters global collaboration and innovation in healthcare.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Flexible Work Hours

Company News

HRKatha
Jun 27th, 2025
AstraZeneca creates 400 jobs, expands its global hub in Bangalore

AstraZeneca creates 400 jobs, expands its global hub in Bangalore.

Devdiscourse
Jun 18th, 2025
AstraZeneca's Stake in Niox Group: A Strategic Partnership | Headlines

AstraZeneca PLC has acquired a significant stake of 15.86% in Niox Group PLC, according to a recent company filing. This move signals strategic collaboration opportunities between the two companies, potentially aligning their interests in the pharmaceutical industry and expanding their influence in the sector.

InfBusiness
Jun 17th, 2025
Scientists present AI solution for protein folding

Scientists from the University of Sheffield, in partnership with AstraZeneca, have developed an artificial intelligence system called MapDiff, which allows for more efficient creation of proteins with a giventhree-dimensional structure and biological functions.

Cision
Jun 13th, 2025
Astrazeneca Enters Into Collaboration With Cspc

AstraZeneca enters into collaboration with CSPC

Cision
Jun 6th, 2025
Fixed-Duration Calquence Approved In Eu For 1L Cll

Fixed-duration Calquence approved in EU for 1L CLL